why choose us

First received: November 02, 2023

Clinical Trial: Using Novel Imaging to More Safely Treat Neuroendocrine Tumors

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Neuroendocrine Tumors
Somatostatin Receptor-positive Neuroendocrine Tumor

Study Type: INTERVENTIONAL


Official Title: Dosimetry-Guided 177Lu-DOTATATE Treatment Planning Using 64Cu-DOTATATE as a Surrogate

Brief Summary: The goal of this research is to determine if DetectnetTM PET/CT can be used to make Lutathera therapy safer for patients with neuroendocrine cancer.Participants will:* Complete two phases involving 6 visits* Undergo additional research PET/CT, and possibly SPECT/CT scans

Read more